Predictors of adherence to sublingual immunotherapy for Japanese cedar pollinosis: a prospective analysis

被引:3
作者
Kikkawa, Sayaka [1 ,3 ,5 ]
Kamijo, Atsushi [1 ,3 ]
Nakagome, Kazuyuki [2 ,3 ]
Soma, Tomoyuki [2 ,3 ]
Kobayashi, Takehito [3 ,4 ]
Uchida, Yoshitaka [2 ,3 ]
Kase, Yasuhiro [1 ,3 ]
Nagata, Makoto [2 ,3 ]
机构
[1] Saitama Med Univ Hosp, Dept Otorhinolaryngol, 38 Morohongo,Moroyama Machi, Saitama 3500495, Japan
[2] Saitama Med Univ Hosp, Dept Resp Med, Saitama, Japan
[3] Saitama Med Univ Hosp, Allergy Ctr, Saitama, Japan
[4] Saitama Med Univ Hosp, Dept Gen Internal Med, Saitama, Japan
[5] Chigasaki Cent Hosp, Dept Otolaryngol, Chigasaki, Kanagawa, Japan
关键词
Adherence; Japanese cedar pollinosis; patient characteristics; questionnaire; sublingual immunotherapy;
D O I
10.12932/AP-200219-0499
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Sublingual immunotherapy (SLIT) often has low adherence rates. Objective: To provide effective support for SLIT continuation, we investigated potential predictors of SLIT adherence through a prospective analysis of patient characteristics. We excluded evaluation of treatment effect and symptoms during treatment, aiming instead to identify predictors of later dropout or insufficient adherence due to indolence or forgetfulness using only information obtained at initial examination. Methods: We provided patients with a questionnaire and monitored self-reported adherence once every 6 months. Cas-es of dropout for clear reasons were excluded, but cases of dropout or insufficient adherence to SLIT for indolence or forgetfulness were included. Results: Fifty-three patients receiving SLIT were assessed. Nine patients dropped out after providing a clear reason. Thirty-four patients maintained good adherence. Seven patients continued SLIT but with insufficient adherence, while three patients discontinued SLIT for unclear reasons (indolence or forgetfulness) and these ten individuals were clas-sified as the poor-adherence group. Univariate analysis and multivariate logistic regression analysis of the good-ad-herence and poor-adherence groups showed age to be a significant predictor of SLIT adherence. Based on analysis of a receiver operating characteristic curve, age < 40.5 years was selected as the optimal cutoff value for predicting poor adherence to SLIT. Conclusion: To prevent treatment SLIT discontinuation on account of indolence or forgetfulness, the necessity of long -term treatment continuity should be communicated clearly prior to commencing treatment, especially for patients under 40 years of age.
引用
收藏
页码:266 / 271
页数:6
相关论文
共 17 条
[1]  
Aboshady OA, 2014, CLIN EXP OTORHINOLAR, V7, P241
[2]   Age-Related Differences in Antihypertensive Medication Adherence in Hispanics: A Cross-Sectional Community-Based Survey in New York City, 2011-2012 [J].
Bandi, Priti ;
Goldmann, Emily ;
Parikh, Nina S. ;
Farsi, Parisa ;
Boden-Albala, Bernadette .
PREVENTING CHRONIC DISEASE, 2017, 14
[3]   The Special Challenge of Nonadherence With Sublingual Immunotherapy [J].
Bender, Bruce G. ;
Oppenheimer, John .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (02) :152-155
[4]  
Costa PT, 1992, Revised Neo-Personality Inventory (NEO-PI-R) and Neo Five-Factor Inventory (NEO-FFI) Professional Manual
[5]   Patients' compliance with different administration routes for allergen immunotherapy in Germany [J].
Egert-Schmidt, Anne-Marie ;
Kolbe, Jan-Marcel ;
Mussler, Sabine ;
Thum-Oltmer, Susanne .
PATIENT PREFERENCE AND ADHERENCE, 2014, 8 :1475-1481
[6]  
Hashimoto H, 1999, JPN J HOSP PHARM, V25, P634
[7]   Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy [J].
Kiel, Menno A. ;
Roder, Esther ;
van Wijk, Roy Gerth ;
Al, Maiwenn J. ;
Hop, Wim C. J. ;
Rutten-van Molken, Maureen P. M. H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (02) :353-+
[8]   Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center [J].
Lemberg, Marie-Luise ;
Berk, Till ;
Shah-Hosseini, Kija ;
Kasche, Elena-Manja ;
Moesges, Ralph .
PATIENT PREFERENCE AND ADHERENCE, 2017, 11 :63-70
[9]  
Ohta N, 2019, NIPPON JIBIINKOKA GA, V122, P35
[10]  
Onishi K, 2018, NIHON BIKA GAKKAI KA, V57, P572